PATZ1 and diffuse large B-cell lymphoma: By analyzing a public dataset through microarray analysis and visualization platform (http://r2.amc.nl), we found that PATZ1 low expression correlates with poor survival in a cohort of 470 human DLBCL patients treated with R-CHOP immunochemotherapy [25].